Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Sep 14.
Published in final edited form as: Chem Rev. 2011 Jul 27;111(9):5768–5783. doi: 10.1021/cr100006x

On the reactivity of thioredoxin as a protein thiol-disulfide oxidoreductase

Zhiyong Cheng †,, Jinfeng Zhang , David P Ballou , Charles H Williams Jr †,*
PMCID: PMC3212873  NIHMSID: NIHMS314705  PMID: 21793530

1. Introduction

Thiol-disulfide reactions are crucial for redox homeostasis in the cell.1-2 As a disulfide oxidoreductase, thioredoxin (Trx, ∼12 kDa) regulates a wide variety of biological molecules in both eukaryotic and prokaryotic species, including ribonucleotide reductase, peroxiredoxin, methionine sulfoxide reductase, phosphatase and tensin homolog (PTEN), transcription factors such as nuclear factor-κB (NF-κB), redox factor-1 (Ref-1), and activator protein-1 (AP-1).3 Thus, Trx has been implicated in such diverse processes as antioxidant defense, DNA repair and synthesis, redox regulation, and apoptosis.4-9

In the evolution of Trx catalysis important physical factors (e.g., a hydrophobic binding groove) have appeared to make Trx bind the disulfide substrate in a specific fashion and generate stabilizing interactions.10-11 The interactions and substrate binding were shown to regulate the geometry and orientation of the target disulfide in the catalytic site of the enzyme, and account for Michaelis-Menten–type kinetics of disulfide reduction by Trx.10-11 Trx molecules contain two cysteines in the active site in a CXXC motif. The chemistry of Trx-catalyzed protein disulfide reduction following substrate-binding includes a nucleophilic attack on the disulfide of target proteins by the N-terminal cysteine thiolate of Trx (which is Cys32 in the E. coli numbering) to form an intermolecular mixed disulfide, and a subsequent attack on the disulfide intermediate by the thiolate of the C-terminal cysteine of Trx (Cys35), producing the reduced target protein and oxidized Trx (Figure 1).12-13 To date a number of factors, including the identity of the amino acid residues spanning the CXXC motif, the pKa of the redox active thiols, the redox potential of the disulfide/dithiol couple, the acid/base catalysts, the molecular interactions and the local conformational changes after substrate binding, have been implicated in the regulation of Trx activity as a protein disulfide oxidoreductase, albeit with controversies and debates. In this work, we review the emerging evidence that support or dispute the regulating roles of these factors, and propose the likely prime determinants of Trx activity that deserve more attention in future research, with the hope to promote a better understanding of the mechanistic factors of Trx reactivity.

Figure 1.

Figure 1

A schematic cartoon view of a Trx-catalyzed disulfide reduction. A number of factors are involved in the regulation of Trx activity, including the amino acid residues spanning the redox active CXXC motif, molecular interaction (e.g., electrostatic force), acid/base catalysts (B1 and B2), conformational adjustment to orientate the reactive groups to facilitate reaction, and hydrophobic microenvironments formed after substrate binding (indicated in pink). Taking EcTrx as an example, the reaction of Trx with target disulfide proteins includes binding (panel A to B), the first nucleophilic attack of Cys32-S- (somewhat exposed to the solvent, panel A) on the target disulfide to form an intermolecular mixed disulfide intermediate (panel B to panel C), followed by a second nucleophilic attack of Cys35-S (buried in EcTrx) on the mixed disulfide (panel C), with the generation of Trx-S2 and the reduced protein (panel D). Binding of the protein substrate to Trx could create a more apolar environment for Cys32 and place it in proximity to acid/base catalysts. However, the identity of acid/base catalysts still remain to be established, although they are critical for the ionization of thiol groups in CXXC motif for nucleophilic attack.

The 3-D structures of Trx proteins are highly conserved, with the five central β-strands surrounded by four α-helices (Figure 2, A and B). Part of the redox active center (-CGPC- motif) protrudes at the surface of the molecule at the very N-terminus of helix α2, with Cys35 largely covered by the N-terminal portion of the helix α2. Only one side of the Cys32-SH is accessible to solvent for the transfer of reducing equivalents in Trxox but the side chain of Cys32 turns into the solvent upon reduction.14-16 The Trx fold is also found in several other classes of enzymes that interact with substrates containing either disulfides or dithiols. Protein families that have a Trx-fold include the thioredoxin, Dsb (disulfide bond formation protein) proteins, glutaredoxin (Grx), glutathione S-transferase, and protein disulfide isomerase (PDI) families.2,16-17 We performed a structural bioinformatics study on 515 sequences of the Trx family, 495 sequences of the DsbA family, and 382 sequences of the PDI family (from the Conserved Domain Database (CDD),18 http://www.ncbi.nlm.nih.gov/sites/entrez?db=cdd). This search confirmed a recent observation that the two components that are most conserved across these 3 families of proteins include an active site CXXC motif, and a conserved proline that is distant in sequence from this active site but immediately adjacent in 3 dimensional space.19 In the Trx family, the CXXC motif has the sequence CGPC and is present at position 32–35, while the proline residue is at position 76 in its best-studied member, E. coli thioredoxin 1 (EcTrx; PDB: 2TRX_A) (Figure 2C). The highly conserved proline is at position 151 in E. coli DsbA (PDB: 1DSB_A) and at position 83 in human PDI (PDB: 1MEK) (Figure 2, D and E). In EcTrx, the distances between the N-atom of Pro76 and the two sulfur atoms of the cysteine pair are 4.07 Å (Cys32) and 3.62Å (Cys35) (Figure 2F). The next closest residue is Asp26, and the shortest distance between an O-atom of Asp26 and the sulfur atom of Cys35 is 5.59 Å (Figure 2G). Pro76 and Asp26 have been shown to play important roles in the redox reactions due to their close contact with the Cys pair.20-21

Figure 2.

Figure 2

Figure 2

The structure of EcTrx and conserved amino acid residues in the Trx family. (A) and (B) are the ribbon diagrams of oxidized and reduced EcTrx, respectively. They show the spatial distances between Trp28 and Cys32, and between Trp28 and Asp26. The color of the backbone labels the secondary structures, where red indicates alpha-helices, yellow indicates beta-sheets, and gray indicates turns or coils. The atom coordinates of proteins are obtained from the PDB,141 and the figures of protein structures were generated using RasMol.142 (C-E) show the conserved residues with sequence alignments of 515 Trx sequences (C), 495 DsbA sequences (D), and 382 PDI-α protein sequences (E) from the Conserved Domain Database of NCBI (note that only the more conserved residues are shown).18 For each panel,(C) - (E), the top portion shows the relative conservation of residues at each conserved position, the middle shows the consensus sequence, and the bottom portion shows the Master Sequence of each class (2TRX_A, 1DSB_A, and 1MEK, respectively). The Master Sequence is that of a real protein, and is the sequence to which all other sequences in the Conserved Domain (CD) alignment are related pair-wise. The Consensus Sequence for a CD contains, at each position, the most frequently occurring amino acid at that position in the alignment of the CD. The relative heights of the green boxes show the residue (in black) having the highest fraction among all the aligned sequences. The color gradation from green to red indicates a decreased conservation of the corresponding residue. From the alignment of the Master Sequences, we can see that the two Cys residues of the three representative proteins (32 and 35 of 2TrxA, 30 and 33 of 1DsbA, and 36 and 39 of 1MEK) are highly conserved in their corresponding families. The alignment also suggests a proximal proline is almost completely conserved in these families (Pro76 in EcTrx, PDB: 2TrxA; Pro151 in EcDsbA, PDB: 1DsbA; and Pro83 in human PDI, PDB: 1MEK). (F) Spatial distance of active site residues Cys32 and Cys35 from Pro76 in EcTrx. (G) Spatial distance between Asp26 and Cys35, and between Pro76 and Cys35 of EcTrx.

Conserved structural features such as the Trx-fold and secondary structure in Trx family members, never-the-less, allow diverse reactivities in catalyzing protein disulfide interchange reactions. Quantum mechanical calculations suggest that the relative stability of thiolates in the CXXC motif determines whether these enzymes catalyze oxidation, reduction, or isomerization.2,22-23 Because the cysteine thiolates in Trx are both poorly stabilized, Trx is a good reducing agent. In contrast, DsbA stabilizes both cysteine thiolates and thus is a good oxidizing agent; isomerases such as PDI have one thiolate relatively solvent exposed and poorly stabilized while the other (relatively buried) thiolate is highly stabilized.22-23 Static calculations, such as the quantum mechanical calculations, provide insights into the thermodynamics of thiol-disulfide reactions, but as previously noted and as recently further investigated,1,24 the reactivity in an actual reaction is more complex due to dynamics and conformational changes that occur during substrate binding. For instance, studies with site-specific mutagenesis indicate that the relative stability of the oxidized versus the reduced form determines the difference in the redox potentials of Trx from Staphylococcus aureus (SaTrx).25-27 Replacement of the conserved proline in the CXXC motif by threonine or serine greatly reduced the relative stability value and made SaTrx less reducing.25 Moreover, the activation energy barrier for forming a transition state complex must be overcome by dynamics or other properties to accomplish a thermodynamically favorable thiol-disulfide reaction.1 However, DsbA from Staphylococcus aureus shows identical stabilities in oxidized and reduced forms, suggesting that alternative mechanisms beyond thermodynamic stability underlie the activity of SaDsbA in thiol-disulfide reactions.28-29

In this work, we review recent studies on the reactivity of thioredoxins as a protein disulfide oxidoreductase. Our goal is to provide an updated view and a better understanding of the determinants of Trx reactivity and their critical roles in redox homeostasis.

2. pKa values of the active thiols in the CXXC motif

The pKa of the thiol of a reactive cysteine residue determines what fraction of the cysteine will be in the thiolate form (RCH2S), which is required for nucleophilic attack on a disulfide (Figure 1). Cysteines with low pKa values are ionized and can be highly reactive in buffers of physiological pH, but the lower pKa values also are associated with lower intrinsic nucleophilicity and higher redox potentials.1 Thus, there is considerable evidence that the pKa values of cysteine residues in thioredoxin family members have multiple effects on their reactivity.1 It has been found that mutations of the dipeptide between the two active site cysteine residues in the thioredoxin family of proteins alter the redox potential of the resulting variants in ways that can at least in part be explained by the effects of these alterations on the thiol pKa values.25, 30-32 For example, when the intervening dipeptide of the reactive dithiol motif in EcTrx was replaced by the dipeptide from glutaredoxin, PDI, or DsbA, all the variants had lower Cys32-SH pKa values and increased redox potentials relative to wild type Trx.31 The glutaredoxin-like variant had the lowest pKa value (5.9) and the highest redox potential (ΔEm = 75 mV), as reflected by the 420-fold decrease in the equilibrium constant (KGSH/GSSG or Kox) for its reaction with GSSG compared to wild type (Equations 1 and 2).

Trx(SH)2+GSSGk2k1GSSTrxSHk4k3Trx(S)2+2GSH (1)
KGSH/GSSG=[Trx(S)2][GSH]2[Trx(SH)2][GSSG]=k1k3k2k4 (2)

For at least some thioredoxin-related proteins, such as DsbA, it has been reported that there is a clear and simple relationship between cysteine pKa values and redox potentials, i.e., the lower the pKa of the resultant thiols, the easier it is to reduce the disulfide bond.30,33 However, the situation appears to be more complicated for thioredoxin.33 On the basis of the substitution effects on rate constants, Mossner et al. tried to predict redox potentials and Cys32 pKa values, but wtTrx was always an outlier in simulations. For example, the calculated Kox value of wtTrx based on this correlation was 22-fold lower than the experimental one.32 Moreover, DsbA- and PDI-like variants of Trx showed 3-fold changes in the maximal reactivity of the Cys residue thiolate (analogous to Cys32 in EcTrx) with iodoacetamide, and this could be expected to reflect the changes in their pKa values; however, all of the pKa values of Cys32-SH were virtually identical.31 Additionally, Trx from the hyperthermophilic archaeon Methanococcus jannaschii (MjTrx) was a stronger reducing catalyst than EcTrx despite an intrinsically lower pKa of 6.28 versus the pKa of 7.1 for EcTrx (see Table 1), arguing against the pKa being the sole determinant of the reactivity and the redox potential of Trx.34 Therefore, Trx reactivity is associated with the pKa value, but the relationship is not straightforward. Consistent with this, theoretical studies on cysteine-containing small molecules and proteins indicated that features causing decreased thiol pKa values also caused decreased nucleophilicity of the nascent thiolate, hence making it less reactive.1 Particularly, the presence or introduction of electron-withdrawing groups or positive charges in proximity to the thiol decreased the pKa by stabilizing the negative charge of the thiolate anion;20,31,35 however, both decreased and increased values of the equilibrium constants for the thiol disulfide reactions were observed despite a general increase in the rate of disulfide bond formation.36 The effects of thiolate stability on the reactivities of Trx family members were investigated recently using quantum mechanical calculations.22-23,37 These studies suggested that the degree of overall stabilization of thiolates in the active site determines whether the thiol-disulfide reaction equilibrium shifted toward reduction, oxidation, or isomerization in reactions associated with Trx, DsbA, or PDI, respectively.22-23 In particular, the presence of proline in the CXXC motif was found to decrease the overall stability of the attacking thiolate in Trx and render the thiol prone to oxidation.22-23, 25 Of note, the conserved central proline also critically mediates the thermodynamic stabilities of Trx and its driving force to reduce substrate proteins.25 The oxidized form of wild-type SaTrx is far more stable than the reduced form, with a relative stability Δ(T1/2)ox/red of 15.5 °C. However, mutation of the central proline (Pro31) to threonine markedly reduced Δ(T1/2)ox/red to 5.8 °C, concomitant with a 7-fold decrease in the reducing activity relative to wild-type SaTrx.25 Further study suggested the P31T mutation did not introduce extra hydrogen bonds with the sulfur of the nucleophilic cysteine, but induced a more hydrophilic milieu surrounding the nucleophilic cysteine that makes the thiol more reactive (or less stable). As might be expected, the pKa value of the nucleophilic cysteine in the mutant decreased by one pH unit and redox potential increases by 30 mV.25

Table 1.

The pKa values of active thiols in EcTrx measured by different methods.

Thiols pKa values Methods/assays References
Cys32-SH 6.7 Alkylation by IAA or IAM (46) (136)
6.28 Trp28 fluorescence (39)
9-10 UV absorbance (A240) GSSG/GSH equilibria (45)
7.1 Raman spectroscopy (42)
7.4 1H-13C NMR (101)
7.0-7.1 1H-13C NMR (58)
7.5 or 9.2 13C NMR (97)
Cys35-SH
9.0 Alkylation by IAA or IAM coupled to HPLC analysis (46)
9-10 UV absorbance (A240) GSSG/GSH equilibria (45)
7.9 Raman spectroscopy (42)
9.4 1H-13C NMR (101)
7.0-7.1 1H-13C NMR (58)
> 11 13C NMR (97)
13.5-14.0 Density functional theory (37)

Because thiolate is the reacting species in the thiol-disulfide exchange reactions (Figure 1), a number of methodologies have been developed to measure the pKa value of reactive thiols in Trx. These methods include measurements of changes in fluorescence 38-39 or UV absorption at 240 nm (A240),31,34,40 Raman spectroscopy,41-42 NMR analysis,39,43-44 and measurements of the pH dependence of the rate of alkylation.31 Different measurement techniques give pKa values for the Cys32 that vary from 6.3-10.0. The pKa value for the Cys35 is even less well defined, lying somewhere between 7 and 14 (Table 1). The large variation in the values obtained for this important parameter is surprising and somewhat disconcerting, and it has drawn attention to some of the shortcomings of the methods used to measure the pKa values.20,45 For example, because it was thought that the Cys32 thiolate quenched Trp28 fluorescence, the fluorescence changes as a function of pH were plotted to calculate the pKa of Cys32-SH as 6.28.46-48 However, the 3D structure of EcTrx shows that the Cys32-SH is almost 8 Å from the tryptophan ring in Trx-(SH)2, even at its closest approach, while the Asp26 side chain is much closer to the Trp28 ring (average distance between Trp28 Cγ and Asp26 Oδ1 was 4.4 Ǻ (Figure 2A and 2B). 49-51 Given the knowledge that the deprotonation of Asp26 occurs in the range of pH 5-7.7 47, 52and that the Trp28 fluorescence of the D26A variant was less pH-dependent than wild type enzyme within the pH 5-7 range,20 it is more likely that the Trp28 fluorescence changes are due to quenching of the tryptophan emission by the Asp26 side chain rather than the Cys32-S. Given these types of concerns it is clear that at a minimum it is necessary to use several methods to determine pKa values.

We have therefore attempted to re-examine these data with the notion that consideration of all the data together, coupled with the advantages of hindsight, might help to resolve this important question. The data in Table 1 show that most determinations of the pKa of Cys32-SH of Trx are below the 8.5-9.0 value for cysteine that is free in solution or is in unfolded proteins.39,53-54 The likely physical basis for the apparently anomalously low pKa of Trx-Cys32 is its proximity to the N-terminus of an α-helix where the positive dipole of the helix can stabilize the negative thiolate form of Cys32.55-57 The pKa of Trx-Cys35 proved more difficult to measure reliably than the pKa of Trx-Cys32, partly because it is buried in the interior of Trx. Some attempts to measure the pKa of the Cys35 thiol have been made with Cys32 in the free thiol or thiolate form.42,45, 58 However, the more relevant pKa of Cys35 is the one that applies to the dithiol-disulfide interchange between Trx(SH)2 and target proteins; this is when Cys32 is in the form of a mixed disulfide with the target protein (Figure 1).

It should also be kept in mind that the pKa values of Cys32-SH and Cys35-SH in Table 1 are based on static measurements in the absence of protein ligands (e.g., A240, NMR, and Trp28 fluorescence); unfortunately, static measurements are not necessarily informative about how dynamic processes affect the relevant pKa values during the docking of a target protein onto Trx.24 Szajewski and Whitesides examined Brønsted coefficients for the dithiol-disulfide reaction between dithiothreitol and GSSG, and have developed an equation that relates the rate constant for steps of the interchange reaction to the pKa values of the nucleophilic, central, and leaving group thiols.53

logkobs=(6.3+0.59pKanuc0.40pKac0.59pKa)lglog(1+10pKa,nucpH) (3)

where pKanuc, pKac, and pKalg are the pKa values of the nucleophilic, central, and leaving group sulfurs, respectively; 6.3 is the log of the pH-independent rate constant. The Brønsted coefficients are explained in the Discussion of reference 53.

As discussed more fully in Section 5, conformational changes occur in Trx through strong molecular interactions during substrate recognition and binding, and these can generate a local hydrophobic milieu and a juxtaposition of titratable groups that affect the pKa values of the Trx thiols and their net reactivity.59-60 Some attempts were made to use the kinetics of the reaction of Trx with GSSG (or IAM) to estimate the pKa values,45-46, but these processes are somewhat different than reactions of Trx with proteins. For instance, thiol-containing proteins react with TrxS2 orders of magnitude faster than with small molecule thiols, presumably because conformational changes and re-orientation of reactive groups occur during protein-protein binding that act to accelerate the reactions.5,39-40,45,53,61-63

Therefore, to account, in part, for the contribution of dynamic structural factors, a correction factor (Fc) has been introduced into the empirical Equation 3 to yield Equation 4 for calculating rate constants of steps in the reaction of Trx(SH)2 with proteins.31-32

logkobs=(6.3+0.59pKanuc0.40pKac0.59pKa)lglog(1+10pKa,nucpH)+Fc (4)

These equations show that in addition to the pKa values of Cys32-SH and Cys35-SH in Trx, the thiol pKa of the target (GSSG or client protein) also contributes to the dependence of the observed rate constant and the overall equilibrium constant of the reaction on the pH of the buffer. For the second nucleophilic attack that occurs on the mixed disulfide by the Cys35 thiolate, the pKa value of GS-S-Cys32-Trx-Cys35-SH or RS-S-Cys32-Trx-Cys35-SH, instead of Trx-Cys35-SH, should be used to calculate the rate constant kobs (k3, the rate constant for the third step of the interchange reaction). However, the pKa of GSS-Trx-SH or the relevant pKa values of Cys35 thiols that contribute to Trx reactivity have not been measured because the rate of mixed disulfide intermediate formation is slow relative to its rate of resolution.64 It is not sufficient to use static pKa values for evaluation of reactivity because (1) in addition to not being reproducible by the different methods of measurement, the static pKa also fails to reflect the dynamic effects in the reaction, (2) reliable pKa values of protein-Trx-SH mixed disulfides are unavailable, and (3) there is no consensus for the pKa values of Trx-Cys35-SH. Recent studies with computational methods such as molecular simulation (MD) have revealed that structural factors, particularly conformational changes during the reaction, could critically regulate the relevant pKa values of active thiols and dissociation of the mixed disulfide intermediate complex between Trx family members and target proteins.24,37,65

3. Redox potential of the active thiols in the CXXC motif

Oxidized and reduced Trx form a conjugate redox pair. The redox potential is related to the ratio of the oxidized to the reduced component at equilibrium and can be calculated with the Nernst equation (see Equations 5 and 6).1,66 This also applies to target disulfide reagents (RS2) that potentially react with Trx(SH)2 (Equations 7 and 8). Equations (5) and (7) are the oxidative and reductive half reactions, respectively, of the thiol-disulfide reaction between Trx(SH)2 and RS2 (Equation 9). Eo(Trx) and Eo(RS2) represent the standard state redox potentials at pH 7 (Em or E1/2) of Trx and the disulfide reagent, respectively); n refers to the number of electrons transferred and F is the Faraday constant. Under the standard state conditions common in biochemistry, the redox potential is standardized as a reduction potential at pH 7, 25 °C (Eo′ or Em7). All other chemical participants are standardized at 1 M.) Equation 10 defines the equilibrium constant, Keq, of the reaction between Trx(SH)2 and RS2. Eh refers to the redox potential of either reacting pair of thiol-disulfide reactions at the experimental concentrations of oxidized and reduced forms. When the system is at equilibrium, Eh is identical for both conjugated redox pairs (Equation 11).

Therefore, if the Eo′ of the RS2/R(SH)2 couple is known, the redox potential of Trx can be calculated using Equation 12 (ref 66, and references therein). The more negative the redox potential of the active thiols in the CXXC motif, the more reducing is the Trx. Using these relationships, the redox potentials of a number of thioredoxins have been determined.34,67-71

graphic file with name nihms314705e1.jpg (5)
graphic file with name nihms314705e2.jpg (6)
graphic file with name nihms314705e3.jpg (7)
graphic file with name nihms314705e4.jpg (8)
graphic file with name nihms314705e5.jpg (9)
graphic file with name nihms314705e6.jpg (10)
graphic file with name nihms314705e7.jpg (11)
graphic file with name nihms314705e8.jpg (12)

Based on the Em values available in the literature for the Trx superfamily, the thioredoxin family is the most reducing group (with Em values -260 to -285 mV at pH 7, 25 °C for most thioredoxins).66-70, Glutaredoxins (Grx) are somewhat less reducing (-198 mV to -233 mV),67 protein disulfide isomerases (PDI) have intermediate redox values (-147 to -175 mV),71-72 and DsbA(s) are the most oxidizing (-90 mV to -110 mV).33, 73 The –XX– dipeptides that intervene between the two cysteines have been shown to influence the redox potential, with G-P, P-T, P-H, and G-H found in Trx, Grx, DsbA, and PDI, respectively. Thus, upon replacing CGPC of EcTrx with CGHC (found in PDI), the redox potential increased modestly toward that of PDI (ΔEm = 35 mV),74 and the inverse mutation (G-H → G-P) in PDI led to a variant that was more Trx-like (ΔEm = -66 mV);75-76 similarly, the replacement of PH in DsbA by GP resulted in a Trx-like DsbA and a 1,200-fold decrease in Keq for the reaction with GSH.73,77 These interesting studies have revealed a reasonable quantitative correlation between the Em values and the activities in reacting with small molecule disulfide reagents (Table 2).78 The plots of Em vs. reactivity of thioredoxin and the Grx-, DsbA-, and PDI-like variants yielded an average linear correlation coefficient of r ≥ 0.90 (Supplementary Figure 1, A-E). Studies extended to Trx-protein reactions showed a similar linear pattern for the Em-reactivity relationship (r = 0.99) (Table 3, Supplementary Figure 2A).78 These correlations strongly indicate that redox potential plays an important role in the thiol-disulfide interchange reactions.

Table 2. The activity of EcTrx, DmTrx, PfTrx, TbTrx and EcTrx variants in reacting with thiol compounds.

Trx and mutants Em
(mV)
k (DTTred)a
(M-1s-1)
k (DTTox)a
(M-1s-1)
k (lipoic acid)a
(M-1s-1)
k (sulfate)b
(mm)
k (methionine sulfoxide)b
(mm)
k(GSSG)c
(M-1s-1)
Wild type DmTrx (CGPC) -287 d - - - - - 170
Wild type PfTrx (CGPC) -284 d - - - - - 650
Wild type TbTrx (CGPC) -282 d - - - - - 23
Wild type EcTrx (CGPC) -296 d - - - - - 100
Wild type EcTrx (CGPC) -270 e 1.1 8.8 313 2.3 1.8 -
PDI-like EcTrx (CGHC) -221 e 24 5.8 55.8 1.3 0.83 -
DsbA-like EcTrx (CPHC) -204 e 46 2.4 11.6 0.4 0.55 -
Grx-like EcTrx (CPYC) -195 e 47 3.3 9.7 0.12 0.17 -
a

The preliminary data were from ref. 78.

b

The reduction of sulfate and methionine sulfoxide was measured with trxA, grxA strain FÅ47 and trxA, metE strain A313, respectively. The trxA, grxA strain FÅ47 was transformed with the pBAD33 derivatives containing the genes of the corresponding thioredoxin variants and then grown at 37 °C on agar plates with M63 minimal medium (containing 10 g/liter ammonium sulfate as sole source of sulfur). Similarly, the trxA, metE strain A313 was transformed with the pBAD33 derivatives containing the genes of the corresponding thioredoxin variants and grown at 37 °C on agar plates with M63 minimal medium supplemented with methionine sulfoxide as sole methionine source. The preliminary data were from ref. 78.

c

The preliminary data were from ref. 66, 70, 79-80.

d

The redox potentials of EcTrx, DmTrx and PfTrx determined at pH 7.0, 25 °C as reported 66 were recalculated for pH 7.4 at which the GSSG reduction rates were measured.79-80 The redox potential of TbTrx determined at pH 7.0, 25 °C 70 was recalculated for pH 7.5 at which the GSSG reduction rate was measured in the same work.

e

The redox potentials of wild type EcTrx and variants are from ref. 78.

Table 3.

The catalytic efficiency (kcat/Km) of EcTrx and EcTrx variants in reacting with thioredoxin reductase (TrxR) or ribonucleotide diphosphate reductase (RDR).

Km (μM) kcat/Km (M -1s -1)


Trx variants Em (mV) TrxR RDR TrxR RDR
Wild type (CGPC) a -284 - - - -
Wild type (CGPC) b -270 2.7 - 1.1 × 107 -
PDI-type (CGHC) b -221 1.4 - 1.6 × 107 -
DsbA-type (CPHC) b -204 1.2 - 1.9 × 107 -
Grx-type (CPYC) b -195 1.2 - 1.9 × 107 -
Wild type (CGPC) c -260 (-282) 1.8 2.0 1.4 × 107 1.5 × 10 6
Trx D26A (CGPC) c -258 (-280) 10.8 33.3 2.4 × 106 8.5 × 10 4
Trx P34S (CGPC) c -269 (-291) 1.8 1.2 1.4 × 107 2.3 × 10 6
Trx P76A (CGPC) c -245 (-267) 8.5 18.5 3.7 × 106 2.3 × 10 4
a

As noted in the text, we prefer the value of -284 mV (at pH 7.0, 25 °C, I = 0.28) determined by an improved methodology as reported 88 with precise corrections with regard to pH, ionic strength, temperature, and reference potential, per ref. 89.

b

All the parameters were determined at pH 8.0 and 25 °C for variants involving residues between the redox active cysteine residues (ref. 78). These values were not corrected because a different buffer system was used and the correction factors were unavailable.

c

The redox potentials for wild type Trx and the three Trx variants involving residues other than those between the redox active cysteine residues, were determined at pH 7.0 and 20 °C, based on a reference potential of -305 mV for the NADP+/NADPH couple.82 The corrections to 25 °C and to the correct reference potential for the NADP/NADPH couple, per ref. 89, are given in parentheses. Briefly, the Em of the redox reference NADP/NADPH was corrected to -327 mV according to ref 89; pH correction: -29.5 mV/pH; temperature correction: -1.39 mV/C.

We note, however, that the modified Trx proteins involving residues between the redox active cysteine residues must be distinguished from the variants involving other residues. Specifically, wild type thioredoxins from different species, as measured by reactions with glutathione disulfide (Table 2 and Supplementary Figure 1F), as well as the variants D26A, P34S, and P76A, reacting with NADPH catalyzed by TrxR or RNR (Table 3 and Supplementary Figures 2, C and D), show poor correlation between the Em values and thiol-disulfide interchange activity.66,79-80 Of the four wild-type thioredoxins (EcTrx, DmTrx, PfTrx, and TbTrx), PfTrx reduced GSSG much more rapidly than did EcTrx (650 vs. 100 M-1s-1), although its redox potential appears less reducing than that of EcTrx (-284 vs. -296 mV, pH 7.4, 25 °C) (Supplementary Figure 1F). This result shows that factors in addition to redox potential play a role in determining Trx reactivity. This is not surprising given our discussion of the influence of thiol pKa values on reactivity (Section 2). A recent report indicates that molecular binding interactions that link the two reactant molecules and position the reactive thiols optimally for the reaction increase the effective thiolate concentration and reduce spatial degrees of freedom much like intramolecular reactions.1 Such effects are common for enzymatic processes, whereby the favorable enthalpy of binding is used to overcome the unfavorable entropic effects inherent in bimolecular reactions, namely, the loss of translational and rotational entropy. Thus, the optimal binding of substrates to Trx provides some of the driving force for catalysis; it lowers the effective transition state energy for the reaction.

Sequence alignment of EcTrx, DmTrx, PfTrx, and TbTrx reveals that the amino acid interposed between the two highly conserved residues (Lys-36 and Ile-38 in PfTrx) is not conserved among the Trx family. In PfTrx, residue 37 is the basic arginine, while the analogous residue in EcTrx and DmTrx is the apolar methionine, and a threonine replaces the arginine residue in TbTrx.81 The positively charged arginine at physiological pH may increase the electrostatic interactions between PfTrx and the negatively charged GSSG, and this additional binding parameter could facilitate overcoming the entropic barrier of bringing the reacting groups together in a confined volume and in the optimal orientation for reaction.1,66,79-80 In contrast, in TbTrx the hydroxyl group might diminish electrostatic interactions, which together with its more oxidizing Em could account for the poorer reactivity of TbTrx in reducing GSSG (Table 2, Supplementary Figure 1F).

Consistent with the hypothesis that molecular interactions, in addition to the Em effects, accelerate thiol-disulfide reactions by diminishing the entropic effects of bimolecular reactions, two lines of evidence were obtained from both types of Trx variants, those that involve the residues intervening the active site cysteines and those involving other sites.78, 82 Thioredoxin and variants such as D26A, P34S, and P76A did not show high correlations between their enzymatic efficiency (kcat/Km) and their Em values; the correlation coefficients were only 0.71 in thioredoxin reductase activity (TrxR) and 0.85 in ribonucleotide diphosphate reductase (RDR) activity (Table 3, Supplementary Figure 2, C and D). In contrast, a plot of TrxR or RDR efficiency (kcat/Km) versus 1/Km, a parameter that indicates the enzymatic affinity towards Trx and its variants D26A, P34S, and P76A, exhibited a nearly perfect linear relationship (r = 0.999 and 0.997, respectively) (Table 3, Supplementary Figure 2, E and F). Thus, we find that molecular interactions in this case can play a dominant role in driving the reaction, although Em also contributes. A second example is the linear increase of enzymatic activity with respect to 1/Km that can be related to the affinity of Trx and its variants DsbA-, PDI- and Grx-like (r = 0.99) towards TrxR (Supplementary Figure 2B). This correlation coefficient (0.99) is the same as that of activity versus Em (0.99) (Supplementary Figure 2A), suggesting that both Em and molecular interactions affect Trx reactivity. Therefore, we conclude that large differences in Em are important for the variation in reactivity (e.g., in DsbA-, PDI- and Grx-like variants), but additional factors, such as specific binding, also participate in regulating Trx activity, especially when the differences in Em are small (e.g., in the variants D26A, P34S, and P76A).

Several methods for measurement of Em are based on redox titrations and the equilibrium theory shown in Equations 5-12. In addition, varying ratios of GSSG/GSH or DTTox/DTTred have been used at relatively high concentrations as redox buffers that equilibrate with Trx according to the relevant Keq. In these cases, after Trx has equilibrated with the redox buffers, iodoacetic acid (IAA) was used to rapidly alkylate the remaining thiols, and HPLC or native gel electrophoresis was used to quantify the proportions of oxidized and alkylated (reduced) Trx products. The equilibrium constant Keq could thereby be determined using different ratios of the redox buffers, and from the Keq values obtained, the Em of various Trx family members could be calculated.67-68,71 However, caution must be exercised in the use of these methods as has been pointed out by these authors and others.68, 75,83-85 First, IAA may shift the thiol-disulfide equilibrium of proteins;83 therefore, it is ideal to perform the experiments with different concentrations of IAA to assure that the concentration of IAA does not affect the results.68 Secondly, incomplete or slow quenching of thiol-disulfide exchange reactions may reduce the confidence of Keq and Em values measured by this method.75, 84-85 Third, because of the relationship between the equilibrium constant and the square of the GSH concentration (Equation 2), the error present in the quantification of GSH can be substantial and can be more pronounced in the presence of millimolar or lower concentrations of GSH/GSSG. In 1997, Aslund et al. developed a direct protein-protein method that allows quantification of all species present in a thiol-disulfide interchange reaction using a single HPLC analysis.67 This method is straightforward and operates at micromolar concentrations of oxidized and reduced proteins.34,67, 69-70

Another noteworthy method is the spectrophotometric assay of the kinetic equilibrium of the Trx/NADPH/TrxR system, which is convenient and has been widely used since 1964. 13,66,82,86-88 In this method, non-equilibrium concentrations of NADPH, NADP+, Trx(SH)2 and TrxS2 are mixed together with TrxR, and the system is allowed to come to equilibrium. When the starting concentrations of NADPH and TrxS2 are in excess of equilibrium values, the reaction will proceed towards reduction of TrxS2; conversely, when starting concentrations of NADP+ and Trx(SH)2 are in excess of equilibrium, the reaction will proceed towards oxidation of Trx(SH)2.86 The reaction can be monitored easily and quantitatively by the changes in absorbance due to NADPH. However, if the initial ratios of reactants are far from equilibrium, it has been observed that somewhat unreliable results can be obtained, thereby reducing the confidence in Em values that are calculated from the measured Keq values.66,86,88 To counter this problem, a systematic variation of the initial ratios of [NADP+][Trx(SH)2]/ [NADPH][Trx(S)2] can be conducted as shown in Figure 3.66,88 The plot of initial ratios of concentrations versus the change in absorbance that occurs to reach equilibrium (A340) yields a crossing point where no change in absorbance occurs. This point is the most trustworthy equilibration point for calculating Eo′. The most reliable results are obtained when the initial ratio and concentration of one of the pairs (e.g., [NADPH]/[NADP+]) is kept constant and the ratio of the other pair is varied, but the sum of concentrations of the latter pair remains constant. Using these criteria, a smooth curve can be obtained as shown in Figure 3. It should be noted that the Em of the redox reference (NADP+/NADPH) is sensitive to temperature and ionic strength; thus, the calculated Em of Trx should be corrected according to the reaction conditions (Table 3, footnotes a and c).66, 89

Figure 3.

Figure 3

Plot of the change in A340 as the reaction comes to equilibrium vs. the initial ratios of reactants. The cross-over point where the change in A340 is zero gives the Keq value. Shown are data for determining Keq for DmTrx2 (pH 7.0, 0.1 M potassium phosphate buffer containing 0.3 mM EDTA). The initial ratio of [DmTrx(SH)2]/[DmTrx(S)2] was kept constant at 5. The initial concentrations of NADPH and NADP+ were varied systematically to give the ratios of [NADP]/[NADPH] from 8 to 16, but the sum of the concentrations of NADP + NADPH was maintained at 220 μM. The initial ratios of [NADP] [DmTrx(SH)2]/[NADPH] [DmTrx(S)2] ranged from 40 to 80 accordingly. Further details concerning the calculation and related examples can be found in reference 66. Reprinted with permission from Reference 66. Copyright 2007 American Chemical Society.

Direct protein electrochemistry has recently been shown to be a versatile tool to determine the electron transfer pathway in Trx catalysis and to measure the Em of Trx.90-96 To use this technique, Trx or its variants, are immobilized on a modified gold electrode and uniquely oriented relative to the electrode surface via a histidine tag; this enables the redox mechanism of the protein to be examined electrochemically. Upon scanning the applied voltage in the reducing direction followed by reoxidation in the reverse direction, two one-electron reduction waves were identified for EcTrx. Such studies yielded a range of Em values between -261.5 and -265 mV for EcTrx, and -210 mV for both m and f spinach thioredoxins.91-93 These Em values measured by direct protein electrochemistry are comparable to those calculated from Keq measurements as described above. More importantly, protein-film voltammetry revealed a fast electrochemical connection between a sub-monolayer of the protein being analyzed and the electrode, which has allowed the direct observation of the reversible 2e/2H+ redox couple of thioredoxins.94

Taken together, the redox potentials of the active site thiols play an important role in Trx reactivity. The Em values show a linear correlation with the activities for Trx and Trx variants involving residues between the redox active cysteine residues (DsbA-, PDI- and Grx-like variants) in the Trx superfamily, but the relationship appears more complicated for Trx and Trx variants involving residues other than those between the redox active cysteine residues (D26A, P34S, and P76A). The observation of a reversible reaction with 2e/2H+ stoichiometry suggests that, in addition to electron transfer, proton transfer processes are important in Trx-catalyzed thiol-disulfide reactions.94 In the following section, acid/base catalysts that can promote proton transfer and accelerate the reactions of the Trx superfamily will be discussed.

4. Acid/base Catalysts

Deprotonation of the redox active thiols in the CXXC motif is critical for the generation of the nucleophilic thiolate form that will attack the target disulfide in thiol-disulfide interchange reactions. Factors that affect the deprotonation of reactive thiols, and thus determine the pKa values, influence the acid/base catalysts per se. There are two affecters of the deprotonation of the exposed thiol in forming the mixed disulfide, substrate binding, and the positive charge of helix α2 as discussed in Section 2 and below.55-56 A number of proposed factors affecting the deprotonation of the buried thiol prior to mixed disulfide complex dissociation have been the subject of study and debate for years.24 These include (1) a potential hydrogen bond between the peptidic N of the partially exposed cysteine and the Sγ of the buried cysteine,50-51,24 (2) another hydrogen bond between the buried Cys-SH and the backbone NH of the proximal Trp. 24 (3) proton sharing between the two sulfur atoms of the active site cysteines,101 and (4) a hydrogen bond between the Sγ of the buried Cys, and the conserved, proximal Asp26 (EcTrx numbering) as shown in Figure 2 G; this long hydrogen bond would need to be bridged by a water molecule13,20,46-47,97-100. The positively charged side chain of the proximal Lys36 may not participate in the deprotonation of active thiols because structural study revealed this side chain was disordered and far from the active thiols in reduced Trx.49 In addition, the hypothesis of a hydrogen bond between the Cys35-NH and Cys32-S was questioned due to its incompatibility with the structures: the van der Waals radius of sulfur was such that the Cys32 thiol (in EcTrx) is moved out into the solvent from the pocket where it resides as part of the disulfide bond in Trx-S2.49 Moreover, if the Cys35 amide proton is hydrogen bonded to a negatively charged group, then hydrogen exchange should be significantly slowed. Contrary to the expectation, hydrogen exchange for the Cys35 amide proton is over 104 times faster in Trx-(SH)2 than in Trx-S2.49

The proposal of proton sharing between Cys32-S and Cys35-SH (in EcTrx) was based on the NMR observations showing that titrations of the two thiol groups were intimately linked, and two pKa values are ∼ 1 pH unit above or below 8.4 (the pKa of free cysteine thiol), respectively.101 A close interaction between the two cysteine thiols, possibly proton sharing, could account for the opposite shift of the pKa of the Cys32 thiol and Cys 35 thiol, with the thiolate anion of Cys 32 stabilized through the sharing of the remaining thiol proton, nominally attached to Cys35.101 Furthermore, distances shorter than those corresponding to the sum of the van der Waals radii of the two cysteine S atoms have also been observed by x-ray crystallography for E. coli and human reduced thioredoxins.101 To test the proton-sharing hypothesis, computational methods have been used but provided contrary evidence.37 Upon performing a potential energy surface scan of the transfer of the proton between Cys32 and Cys35 in thioredoxin, the potential energy of the system was plotted versus the distance between the thiol proton and the Sγ of the nucleophilic cysteine.37 If the proton was shared by the two active site cysteines, a curve with a minimal potential energy should appear in the position where the proton was equally shared (with a distance of 1.41 Å); however, the curve reached a maximum around 1.41 Å. Thus, this study argues against the notion of proton sharing.

A possible physical basis for deprotonation of active thiols with an anomalously low pKa (e.g., Cys32 in EcTrx) is the positive dipole of the α-helix that can stabilize the negative thiolate of Cys32.55-57 The Cys32 thiol is positioned directly on the axis of the long helix.55-57 Being in the positive electrostatic field of the N-terminus of an α-helix, Cys32 possibly loses a proton during binding to the substrate protein. The somewhat more apolar environment that is created around Cys32 when substrate binds may intensify the electrostatic effects of the α-helix. Although the Cys35 thiol is also situated close to the N-terminus of the α-helix, the local environment around the Cys35-SH is sufficiently different from that of Cys32, as indicated by the distance from the N-terminus of the α-helix and alignment with the helix axis, as well as its more apolar environment and proximity to the side chain of the buried Asp26.55-57 This could account at least in part for the different pKa values and reactivities of the N- and C-terminal reactive cysteines.

Deprotonation of the buried cysteine thiol is critical for the second nucleophilic attack to complete the thiol-disulfide interchange reaction. However, the factors that mediate the deprotonation are challenging to identify experimentally because the mixed disulfide intermediate forms only transiently.24,102 It was hypothesized that a solvent-mediated proton transfer might take place between Asp26 and Cys35 (in EcTrx) even at a distance of 5.6 Å.13,103, To pursue evidence in this respect, theoretical studies have been conducted on the reduction of dimethyl disulfide by CGPC which contains the active-site of Trx; the study made use of both DFT (density functional theory) calculation and MD (molecular dynamics) simulation. The computations suggested that deprotonation of Cys35-SH occurred directly after the first SN2@S step through proton abstraction by the leaving group, which was released in the vicinity of or in steric contact with the thiol group of the buried Cys35102. However, a caveat is needed; in this case it was not prudent to apply studies involving small molecules to the mechanism of the deprotonation of a buried thiol. Combining theoretical calculations and biochemical experiments, a recent study addressed the mechanisms responsible for the second nucleophilic attack to resolve the mixed disulfide intermediate.24 The formation and resolution of a mixed disulfide in the reaction between SaTrx (with a Cys29-Gly-Pro-Cys32 motif) and the target protein, arsenate reductase (ArsC, with Cys82 and Cys89 in the redox active center), were investigated using DFT calculations and MD simulations of the distance between Asp23Oδ1 or Asp23Oδ2, (analogue of Asp26 of EcTrx) and Cys32Sγ (an analogue of Cys35γ in EcTrx). The distance increased to 10 Å (out of the hydrogen bonding distance of 6Å with a single water molecule) when the leaving thiol Cys82-ArsC was ionized. Instead of solvent-mediated proton transfer, the authors suggested that two hydrogen bonds, Cys32TrxSγ—Cys29TrxN and Cys32TrxSγ—Trp28TrxN were introduced during the local conformational changes; these could activate Cys32Sγ without intervention of Asp23.24 Moreover, mutation of Asp23 in SaTrx (D23A) or Cys82 in ArsC (C82A) did not prevent the mixed disulfide from dissociation in the biochemical complex formation experiments, suggesting Asp23 and Cys82 might not be required for the mixed disulfide formation and resolution.24 These findings strongly suggest that experimental validation is required for theoretical simulation and prediction, although it is a challenging task. Moreover, differences in the mechanism may exist between Trx isolated from several species.

Before the proximal aspartate (Asp26 in EcTrx and Asp23 in SaTrx) is dismissed as a potential acid/base catalyst, however, a few critical issues must be addressed. First, it has been established that factors lowering thiol pKa values can also decrease the nucleophilicity of the nascent thiolate and make it less reactive.1,20,31,35-36 The MD simulation suggested additional hydrogen bonds that were particularly strong based on geometric criteria.24 How such strong hydrogen bonds might lower the pKa of the Cys32-SH in SaTrx but not deactivate the buried thiol(ate) must be addressed to make this hypothesis attractive. Secondly, the observation, in which mutation of Asp23 to Ala did not prevent the mixed disulfide formation and dissociation, does not necessarily exclude Asp23 as a potential acid/base catalyst in the reaction. Asp23 could be one of the acid/base catalysts and function in parallel with others such as the proximal tryptophan (in a catalytic tetrad, to be discussed below), proline (even closer to the reactive thiols than the aspartate, see below), small molecule bases in the buffer, and so-far-unidentified structural factors (particularly those formed during substrate binding and conformational changes). These factors, which may overlap in their function as acid/base catalysts, might adequately compensate for the effect of the mutation of Asp23 on Trx activity. This is particularly true when 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) was used as a disulfide to react with SaArsC C10S/C15A/C82A triple mutant (SaArsCTrip); the resulting mixed disulfide was reacted with reduced SaTrx or SaTrx D23A in the presence of small molecule bases in the buffer. The absence of a mixed disulfide, detectable on a non-reducing SDS-PAGE, between Sa_ArsCTrip and either SaTrx or SaTrx D23A suggests that such a mixed disulfide formed and was resolved as Cys32 attacked Cys29 to form oxidized SaTrx or SaTrx D23A and SaArsCTrip.24

Establishing chemical mechanisms is always difficult, requiring very strict validation of working hypotheses by experimental data.24 Nevertheless, considerable experimental data have emerged to support the potential role of Asp26 as an acid/base catalyst in EcTrx.13, 20, 47, 97-100 This finding is not surprising given that Asp26 in EcTrx is located close to the CXXC motif and has been shown to affect the microscopic pKa values of the active thiols. 97

The D26A variant was found to have only 10% of the activity of wild-type Trx-(SH)2 towards reducing insulin disulfides. In the reaction of Trx-S2 with thioredoxin reductase at pH 8.0, the kcat/Km for the D26A variant was only ∼ 10% that of wild type (7.5 × 105 M-1 s-1 compared to 8 × 106 M-1 s-1).20 In oxidizing DTT, wild-type Trx exhibited substantially greater reactivity than did D26N-Trx at low pH values, but the activities converged to nearly the same value at ∼ pH 9.0.98 If the results are normalized to the thiolate concentrations of DTT that are present, the rates of the reactions follow a normal pH titration curve with a pKa value of 7.23, close to that of Asp26.47, 97-98,100 Thus, when the buffer had a pH that was greater than the pKa value, the effects of Asp26 were greatly diminished.99

To further understand the role of Asp26 in acid/base catalysis, the effects of exogenous bases on the activities of Trx variants at Asp26 were studied.13 In the reduction of DTNB, the inclusion of exogenous bases substantially increased the activities of D26N-Trx and D26L-Trx.13 Interestingly, the rates of D26A-Trx and D26N-Trx in the first step of DTNB reduction, i.e., the formation of the mixed disulfide, were indistinguishable from those of wild-type Trx. However, the rate of the second phase, which corresponds to the cleavage of the Trx/TNB mixed disulfide, differs significantly.13, 98 This difference suggests that Asp26 is likely to react with Cys35 rather than Cys32, consistent with Asp26 being closer to Cys35 than to Cys32 (Figure 2G). The addition of imidazole, acetate, or Tris-base facilitated, in a concentration-dependent manner, the cleavage of the TrxSH/S-TNB mixed disulfide in the Asp26 variants, but had no effect with wild-type Trx. This constitutes strong evidence that Asp26 serves as a base in the reaction of reduced wild type Trx with DTNB, admittedly, an atypical substrate.13 In contrast to these results with DTNB, the buffers had less effect on the Asp26 variants in the cleavage of Trx/TrxR mixed disulfide (even with 0.10 M Tris in the buffer), presumably because the interface of the Trx-TrxR complex limits access to small molecule bases.

A catalytic tetrad was proposed to form among five highly conserved amino acids, in Chlamydomonas reinhardtii thioredoxin h (CrTrxh); Asp30 (analogous to Asp26 in EcTrx), Trp35, the redox-active disulfide, Cys36-Cys39, and Asp65 (Figure 4).44 In the catalytic tetrad, Trp35 is proposed to be involved in a hydrogen bond between its N1–H and the carboxylate of Asp65. This hypothesis seems to extend the H-bonding (or sharing) proposal,49, 101 regardless of the controversy.37 This suggests the conserved tryptophan near the CXXC motif is indirectly involved in the deprotonation of Cys36, and that Asp30 acts as the acid catalyst.44 Experimentally, the W35A mutation in CrTrxh diminished its ability to activate the thiol-regulated NADPH-dependent malate dehydrogenase, although the reduction potential was unchanged. The lesser activity in W35A was attributed to the changes in pH sensitivity of the redox-active thiols. Wild-type CrTrxh showed two apparent pKa values, ∼ 7.0 and 9.5, but the W35A variant had a single pKa of ∼ 8.3. Conceivably, the W35A mutation changed the ionization behavior of the redox active thiols, although it cannot be ruled out that the function of Trp35 in wild-type CrTrxh was primarily structural, to facilitate the optimal orientation of appropriate residues. Consistent with the contribution of tryptophan to acid-base catalysis, mutation that substituted Ala for Trp31 (W31A) in EcTrx (Trp31 is an analogue to Trp35 in CrTrxh) diminished the activity in reducing insulin.104 A structural role may nevertheless be important because Trx-W31F and Trx-W31H exhibited substantial activity, and Trx-W31Y had an activity similar to that of wild-type enzyme; these three mutations are far less drastic than Trp to Ala.104 A nearby lysine residue contributes little to the catalysis, as shown by a single mutation of this residue (Lys57Met in EcTrx) that had no effect on the reactivity.20 It may be noteworthy, that the conserved tryptophan in SaTrx (Trp28) was recently found to be important for the thermodynamic stability of this protein.26 The W28A mutation results in a swapped dimer that is so kinetically stable as to suggest that this mutation might occur and favor other mutations until an evolutionary advantage is obtained. 26

Figure 4.

Figure 4

A schematic view of a proposed catalytic tetrad composed of Asp65, Trp35, the redox-active disulfide (Cys36-Cys39), and the protonated buried Asp30 in CrTrxh. The catalytic tetrad provides both base catalysis toward Cys36-SH, provided by an aromatic side chain of Trp35, and acid catalysis toward Cys39-SH, provided by Asp30. Adapted with permission from Reference 44. Copyright 1998 Wiley-Blackwell.

Proline is traditionally thought to serve a structural role in proteins. Due to the potential cis and trans isomers of the proline peptide bond, for example, Pro76 in EcTrx was found to control the partition between two folded forms that have different stabilities.21,105 However, Pro76 is even closer to the CXXC motif and is more highly conserved than is Asp26 in the Trx superfamily (Figure 2, C and F). It is therefore tempting to speculate that Pro76 facilitates the thiol-disulfide exchange reaction via interactions with the thiols. Consistent with this notion, it was found that the P76A variant of EcTrx had lower activity,21 and mutation of the analogous residue in DsbA (Pro151) significantly inhibited the thiol-disulfide exchange reaction.106 Thus, P151T or P151S mutations in DsbA resulted in detectable accumulation of intermolecular mixed disulfide intermediates, which are generally difficult to detect because they resolve very quickly.106 Although it remains unclear how the proline residue facilitates the thiol-disulfide exchange reaction, the proximity of the proline N-atom to the CXXC motif (3.62 Å) suggests hydrogen bonding to the thiol of the substrate could promote the shuttling of the proton from one sulfur atom to the other without involving solvent (Figure 5). Note that the conserved proline (Pro76 in EcTrx or Pro151 in DsbA) is located at the surface where the family members bind their target proteins and form complexes stabilized within the nascent hydrophobic milieu.107 Without this proton-transfer mechanism, the energy barrier for this reaction could be quite high because it is unlikely that a proton-donating solvent molecule would be trapped inside such a hydrophobic interface to facilitate the proton transfer. We suggest that the hypothesis of Pro76 or Pro151 being involved in a proton shuttle deserves further investigation.

Figure 5.

Figure 5

A schematic hypothesis of Pro151 in DsbA in aiding the shuttling of a proton in the cleavage of DsbA-substrate mixed disulfide.

5. Molecular interactions and conformational factors

Trx binds to a variety of protein substrates and modulates their structures and activities.108 The intermolecular interactions between EcTrx and its substrate proteins leads to high affinity and substrate specificity, resulting in ∼ 104-fold enhanced rates for both the oxidation 109-110 and reduction 111 reactions at neutral pH, as compared to similar reactions with small molecule thiols and unstrained disulfides. As already discussed in Section 3, such effects are common for enzymatic processes, whereby the favorable enthalpy of binding is used to overcome the unfavorable entropic effects inherent in bimolecular reactions.

Due to the crucial role of molecular interactions in accelerating the reaction, Trx derivatives that lack redox active thiol groups, such as S,S′-dicarboxymethyl-dicarboxamidomethyl-thioredoxin or Cys→Ser variants, were capable of activating target proteins using only suboptimal amounts of native thioredoxin that acted as a catalyst.110,112-114 When the affinity of EcTrx toward its targets was changed, e.g., by replacing the neutral Gly31 with charged residues (Lys or Asp), the reactivities with both insulin and TrxR were lessened, although those variants showed redox potentials that were almost identical to that of wild-type Trx.69,87

Chloroplasts contain two well-studied thioredoxins, Trx-f and Trx-m. Trx-f is a potent activator of fructose-1,6-bisphosphatase (CFBPase),115-118 which is important in regulating phosphofructokinase and the balance between glycolysis and gluconeogenesis. The redox-active cysteines of CFBPase that are responsible for its activation are clustered in a solvent-exposed structure formed by the highly negatively charged 170's loop.119-121 In the chloroplast ferredoxin-Trx system that consists of ferredoxin, ferredoxin–thioredoxin reductase (FTR), and Trx-f, the function of Trx-f was found to depend both on molecular interactions and on reductive activation. This redox cascade proceeds most efficiently if the target and other associated proteins form complexes.113-114 Despite their common tertiary structures, the distribution of surface charges differs amongst thioredoxins (Figure 6),14,16,122-123and these surface charges can contribute to electrostatic interactions that enhance the affinity of Trx to its targets. For example, the positively charged residues of chloroplast thioredoxin, Trx-f, favor its binding to CFBPase. Indeed, variants with negatively charged residues substituting for positively charged or neutral residues (K58E, Q75D, and N74D), and deletion mutants (ΔAsn74 and ΔAsn77) lacked much of the ability of Trx-f to activate CFBPase.118 Moreover, the presence of the four basic residues, Arg37, Lys70, Arg74, and Lys97, in pea Trx-m conferred greater efficiency of activation of CFBPase than that of spinach Trx-m, which lacks the positively charged residue corresponding to Lys70 of pea Trx-m. The K70E variant of pea Trx-m exhibited 50% less efficient activation of FBPase than wild type.124 Conversely, replacement of the negatively charged Asp with the uncharged Asn in EcTrx promoted its activation of spinach CFBPase,125 while the increased abundance of Lys in EcTrx variants impaired its ability to reduce a positively charged target protein.126

Figure 6.

Figure 6

Electrostatic properties of thioredoxins. Charge distribution on molecular surfaces of E. coli wild type Trx (a), spinach chloroplast Trx-f (b), E30K/L94K E. coli Trx (c), and spinach chloroplast Trx-m (d), as calculated with GRASP. Electrostatic potentials at the protein surface and superimposed isopotential shells (calculated at ±2 kT) are colored as follows: red as negative and blue as positive. The active site regions of all proteins are located at the center of each image. An S illustrates the position of the accessible sulfur atom of Cys-32. Reprinted with permission from Reference 122. Copyright 1998 American Society for Biochemistry and Molecular Biology.

Computational analysis indicated that the surface of EcTrx (Figure 6a) and of chloroplast Trx-m (Figure 6d) had large negatively charged areas that were absent in Trx-f (Figure 6b). In Trx-f there is an additional positively charged area (marked by the pink rectangle) (Figure 6b) that was not present in either Trx-m (Figure 6d) or EcTrx (Figure 6a).122 Upon introducing two positively charged residues (E30K/L94K) into EcTrx (Figure 6c), the surface charge distribution of wild type EcTrx became more like that of chloroplast Trx-f (marked by the green circles) (Figure 6b).122 The increased number of positive charges was found to substantially enhance the affinity of the EcTrx variants for CFBPase and increase the maximum specific activity.93,122 Specifically, wild type EcTrx and its three variants (E30K, L94K, E30K/L94K) have nearly identical redox potentials, but wild type EcTrx is less active that these three variants towards CFBPase.93,122 Moreover, in spite of Trx-f, having the most oxidizing redox potential among five thioredoxins, it nevertheless exhibited the highest activity in activating CFBPase via reductive activation.93,122 This apparent contradiction can be explained at least in part by the affinity differences among EcTrx and its variants, because wild type EcTrx had the lowest affinity whereas Trx-f had the highest affinity for CFBPase.93,122 It is noteworthy that high concentrations of KCl impaired the affinity of otherwise highly efficient modulators like the EcTrx variant E30K/L94K and chloroplast Trx-f.122 Consistent with this, a quantitative relationship has been developed that links protein interactions with the ionic composition of the solution.127

Conceivably, long range electrostatic interactions can contribute to the formation of a noncovalent Trx-CFBPase complex in which the non-charged patch surrounding the nucleophilic Trx-Cys32 would provide proper complementarities between the interfaces of modulator (Trx) and the target enzyme (CFBPase).113-114,122 Such electrostatic interactions would allow for the recognition and optimal orientation of paired proteins to promote proton transfer, as well as for channeling of relevant substrates.128 Correct docking permits the reactive thiolate anion of Trx to cleave the disulfide bond of CFBPase with the formation of a transient mixed disulfide between the two proteins.

The contribution of electrostatic interactions may also account in part for the differential reactivities of EcTrx, DmTrx, and PfTrx (see Sections 2 and 3) in reducing the negatively charged GSSG, as shown by the substantially higher reactivity of those proteins having positively-charged amino acids in proximity of the active thiols (Supplementary Figure 1F).14,35-36,66,79-80,129

Recently, on the basis of dynamic simulation, a hydrophobic binding groove was proposed, which allows Trx to bind the substrate specifically through stabilizing interactions that results in Michaelis-Menten–type kinetics of disulfide reduction.10-11 This binding groove appears to be deepened across the evolution of Trx catalysis, from bacterial to eukaryotic Trxs. Trx catalysis has been studied using single-molecule force spectroscopy where mechanical force is applied to the disulfide bond of a substrate protein. If the bond is stretched with low force, all Trxs exhibit a Michaelis-Menton mechanism while at high force eukaryotic Trxs reduce disulfide bonds through a single-electron transfer reaction (SET), whereas bacterial Trxs show both nucleophilic substitution (SN2) and SET reactions.10-11

Substrate binding that modulates the structures of the two proteins can enable them to achieve an optimal conformation to facilitate dithiol-disulfide interchange.10-11,24,61-63,128,130-131 Although the overall molecular architecture of the Trx family is similar in both redox states, subtle conformational changes have been identified, particularly in the space surrounding the redox active cysteine residues during dithiol-disulfide interchange.24,50-51,132-133 For instance, the catalytic site of EcTrx was shown to participate in the reorientation or elongation of the substrate disulfide bond, by adjusting the local geometry of the participating sulfur atoms with sub-angstrom (Å) precision to achieve efficient catalysis.11,131 Moreover, the backbone and side-chain of Cys35 in EcTrx undergoes a rotation around the Cα-Cβ bond upon change of the redox state, while Cys32 remains largely fixed (cf. Figures 2, A and B);14 in contrast, formation of the Cys32–Cys35 disulfide causes a rotation of the side-chain of Cys32 away from Cys35 in DmTrx, as does human Trx and spinach chloroplast Trx-m. The movements of Gly33 and Pro34 were smaller in DmTrx than in EcTrx, whereas the movement of the side chain of Phe28 that occurs when DmTrx becomes oxidized was not discernible in EcTrx. The stereo representations in reference 14 are particularly instructive, showing that in the fly enzyme Cys35 is not buried.

These differences in dynamics during changes in the redox states have been attributed to the mechanisms underlying the two distinct modes of catalysis that have evolved in prokaryotic (low molecular weight of 35 kDa) and eukaryotic (high molecular weight of 55 kDa) TrxRs,13,134 and suggests that the evolutionary optimization of Trx activity has been a complex process. Given the structural and mechanistic differences between prokaryotic and eukaryotic TrxRs across the evolutionary tree, it is reasonable to consider that the evolution of the chemical mechanisms found in Trx has been tightly associated with the evolution of TrxR.10-11, 13,134 Particularly, an interconversion between two conformations occurs twice in each catalytic cycle of the prokaryotic TrxR; after reduction of the disulfide by the flavin, the pyridine nucleotide domain rotates with respect to the flavin domain to expose the nascent dithiol for reaction with thioredoxin, This motion also repositions the pyridine ring adjacent to the flavin ring to enable rereduction of the flavin for another catalytic cycle. In the eukaryotic enzyme, however, the rotation of two domains is not necessary, because a third redox active site (disulfide or selenenylsulfide) shuttles the reducing equivalent from the apolar active site thiols to the protein surface where reduction of Trx occurs.134

Under some conditions, dimerization of Trx may occur and cause loss of reactivity due to protein precipitation and aggregation; this may underlie the putative autoregulation of Trx availability and activity in vivo.5, 68, 81, 129,132 For instance, noncovalent interactions, such as hydrophobic interactions arising from abundant apolar residues on the Trx surface, can substantially contribute to its dimerization.129,132 Although not yet discovered in nature, a single mutation of the active-site tryptophan to alanine in SaTrx converts the oxidized protein into a biologically inactive dimer that is extremely stable (see above).26 Thioredoxins that contain additional cysteine residue(s), such as PfTrx (Cys43), TbTrx (Cys67), and human Trx (Cys62, Cys69 and Cys73), are especially prone to form intermolecular covalent dimers.68,81,129 In addition to the intermolecular disulfide/dimerization that reduces Trx activity through aggregation, an intramolecular disulfide formed between the catalytically inactive thiols (i.e., Cys62–Cys69 disulfide of human Trx) impairs Trx activity by disrupting Trx–target protein interactions as indicated in the cartoon in Figure 7.68,135 While it is easy to understand the formation of an intermolecular disulfide between cysteines located on the protein surface (e.g., Cys73 and Cys73′ of two human Trx molecules), the structural factors facilitating the intra- and inter-molecular disulfide bonds between buried cysteines (e.g., Cys62 and Cys69 in human Trx) were only delineated recently.136-137 It was shown that human thioredoxin undergoes a conformational change that unravels helix α3 and exposes residues Cys62 and Cys69 (both buried beneath and located at either end of helix α3) in a more open conformation. 136-137 As such, the buried cysteine residue becomes exposed in the open conformation and generates a structural basis for the cysteine to participate in the inter- and intra-molecular disulfide formation. 136-137 The impaired activity caused by the extremely stable dimerization of oxidized Trx provides a mechanism by which Trx activity is transiently inhibited under conditions of redox signaling or oxidative stress, and allows more time for the sensing and transmission of oxidative signals.68

Figure 7.

Figure 7

A scheme showing that an intramolecular disulfide formed between the catalytically inactive thiols (i.e., Cys62–Cys69 disulfide of human Trx) impaired Trx activity by disrupting Trx–target protein interactions. Due to this impairment, the half-life of the oxidized Trx becomes prolonged, for which Trx activity can be transiently inhibited under conditions of redox signaling or oxidative stress, and allows more time for the sensing and transmission of oxidative signals. Adapted with permission from Reference 135. Copyright 2004 Oxford University Press.

6. Conclusions

Trx catalyzes disulfide oxidoreduction in a wide variety of biological processes that are controlled by dithiol-disulfide interchange reactions. Because the reversible dithiol-disulfide reaction has 2e/2H+ stoichiometry, factors that regulate electron and proton transfer affect the reactivity of Trx family members. Consistent with this notion, the redox potential and pKa values of the active thiols in the CXXC motif show a strong association with Trx reactivity. Moreover, emerging evidence shows that Trx activity can be regulated by the relative stability of oxidized and reduced forms of Trx, molecular interactions (e.g., electrostatic force), acid/base catalysts, conformational adjustments to orientate the reactive groups to facilitate reaction, and hydrophobic microenvironments formed after substrate binding. However, several outstanding questions must be addressed before we fully understand the mechanisms that underlie Trx reactivity as a protein disulfide oxidoreductase.

First, considerable controversy exists in the reported pKa values of the active site thiols. Thus, the use of multiple methods and the development of new, more reliable methodologies are desirable for more accurate measurement of the pKa values for the active thiols in the CXXC motif. In particular, the pKa value of the buried Cys35-SH (in EcTrx), which is important for resolving the mixed disulfide, should be measured in Trx in which the Cys32 thiol is actually in the form of a mixed disulfide (RS-S-Cys32-Trx-Cys35-SH) rather than the form of a free thiol (HS-Cys32-Trx-Cys35-SH). Second, complex rather than simply linear correlations between redox potentials (or pKa values) and reactivity of Trx suggests that other regulating factors as discussed above must be taken into consideration for a reliable simulation of Trx activity. Third, considerable evidence has revealed the critical role of acid/base catalysts in the regulation of Trx activity. Asp26 (in EcTrx) can be one of the acid/base catalysts, but further corroborating evidence is required, as some recent studies have questioned its role in modulating Trx reactivity. The highly conserved residue, Pro76 (in EcTrx) that is uncharged and even closer to the CXXC motif, deserves future attention with respect to its possible role as an aid in shuttling protons during dithiol disulfide catalysis. Fourth, the nature of the nascent hydrophobic milieu, which forms at the surface when thioredoxins bind their target proteins and form complexes, requires further study to understand the residues and the particular interactions involved. Finally, with the realization that its subcellular localization is crucial to defining Trx as a reductant or an oxidant,138-140 more in vivo evidence is needed to establish the nature of Trx reactivity under physiological conditions.

To address these questions, use of new techniques seems to be a promising strategy. For instance, direct protein electrochemistry as a versatile tool has been to employed to determine the electron transfer pathway in Trx catalysis and produce reliable measurement of the Em of Trx comparable to classic methods; this has allowed the direct observation of the reversible 2e/2H+ redox couple of thioredoxins. Single molecule force spectroscopy has emerged as a powerful tool to probe the signature of dynamic sub-angstrom molecular rearrangements within the Trx active site during catalysis. By coupling new techniques with traditional methods (e.g., protein biochemistry, x-ray crystallography, and NMR), future studies on Trx will substantially advance our understanding of the fundamental mechanisms underlying Trx activity and evolution as a protein disulfide oxidoreductase.

Supplementary Material

1_si_001

Supplementary Figure 1. Relationships between Em and Trx reactivity with small molecule disulfide reagents. WtTrx (gray circle) and the three Trx variants, PDI-like Trx (black circle), DsbA-like Trx (gray diamond), and Grx-like Trx (black diamond) showed a reasonably linear relationship between their Em values and their reactivity in reducing DTTox (A), lipoic acid (B), sulfate (C), methionine sulfoxide (D), and in oxidizing DTTred (E). (F) Trx(s) from different species showed poor correlation between the Em values with their reactivity with GSSG. The preliminary data is from Table 3.

Supplementary Figure 2. Differential role of the redox potential and binding affinity in regulating Trx activity to react with proteins. (A) The correlation between the Em of Trx and DsbA-, PDI- and Grx-like variants, and their activity (kcat/Km) in reacting with NADPH catalyzed by TrxR. (B) The relationship between activity of Trx and DsbA-, PDI- and Grx-like variants and their substrate affinity (1/Km) toward TrxR. (C and D) The relationships of Em of Trx and D26A, P34S, and P76A variants with their activities in reacting with NADPH catalyzed by TrxR or ribonucleotide diphosphate reductase (RDR), respectively. (E and F) The relationships between the activities of variants D26A, P34S, and P76A and their substrate affinity (1/Km) toward TrxR or RDR, respectively. The preliminary data is from Table 2. Note that both Fig. 4B and 4E show only 3 points because two of the four points in each panels overlapped. In Fig 4B, two points are located at (0.83, 1.9), and (0.56, 14) in Fig 4E.

Acknowledgments

The authors are grateful to Prof. James C. A. Bardwell, Howard Hughes Medical Institute, Dept. of Molecular Cellular and Developmental Biology and Dept. of Biological Chemistry, University of Michigan for carefully reading the manuscript and for making many substantive suggestions. This work was supported by grants from the National Institute of General Medical Science, GM21444 (to C.H.W.) and GM11106 (to D.P.B.), and by the Health Services and Research Administration of the Department of Veterans Affairs (C.H.W).

Abbreviations list

Trx

thioredoxin

wtTrx

wide-type Trx

EcTrx

Trx from Escherichia coli

PfTrx

Trx from Plasmodium falciparum

DmTrx

Trx from Drosophila melanogaster

TbTrx

thioredoxin from Trypanosoma brucei

CrTrxh

thioredoxin h from Chlamydomonas reinhardtii

SaTrx

thioredoxin from Staphylococcus aureus

Trx-m

chloroplast thioredoxin m

Trx-f

chloroplast thioredoxin f

TrxR

thioredoxin reductase

Trx-S2

oxidized thioredoxin

Trx-(SH)2

reduced thioredoxin

PDI

protein disulfide isomerase

IAM

iodoacetamide

Em

the mid-point redox potential

Keq

equilibrium constant

GR

glutathione reductase

GSH

glutathione

GSSG

glutathione disulfide

Grx

glutaredoxin

Dsb

disulfide bond formation protein

Footnotes

Supporting Information: The Supporting Information consists of two Figures, S1 and S2. This information is available free of charge via the Internet at http://pubs.acs.org/.

References

  • 1.Jensen KS, Hansen RE, Winther JR. Antioxid Redox Signal. 2009;11:1047. doi: 10.1089/ars.2008.2297. [DOI] [PubMed] [Google Scholar]
  • 2.Hatahet F, Ruddock LW. Antioxid Redox Signal. 2009;11:2807. doi: 10.1089/ars.2009.2466. [DOI] [PubMed] [Google Scholar]
  • 3.Jeong W, Yoon HW, Lee SR, Rhee SG. J Biol Chem. 2004;279:3142. doi: 10.1074/jbc.M307932200. [DOI] [PubMed] [Google Scholar]
  • 4.Powis G, Montfort WR. Annu Rev Pharmacol Toxicol. 2001;41:261. doi: 10.1146/annurev.pharmtox.41.1.261. [DOI] [PubMed] [Google Scholar]
  • 5.Lillig CH, Holmgren A. Antioxid Redox Signal. 2007;9:25. doi: 10.1089/ars.2007.9.25. [DOI] [PubMed] [Google Scholar]
  • 6.Yoshioka J, Schreiter ER, Lee RT. Antioxid Redox Signal. 2006;8:2143. doi: 10.1089/ars.2006.8.2143. [DOI] [PubMed] [Google Scholar]
  • 7.Michelet L, Zaffagnini M, Marchand C, Collin V, Decottignies P, Tsan P, Lancelin JM, Trost P, Miginiac-Maslow M, Noctor G, Lemaire SD. Proc Natl Acad Sci USA. 2005;102:16478. doi: 10.1073/pnas.0507498102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ahsan MK, Nakamura H, Tanito M, Yamada K, Utsumi H, Yodoi J. Free Radic Biol Med. 2005;39:1549. doi: 10.1016/j.freeradbiomed.2005.07.016. [DOI] [PubMed] [Google Scholar]
  • 9.Arner ESJ, Holmgren A. Eur J Biochem. 2000;267:6102. doi: 10.1046/j.1432-1327.2000.01701.x. [DOI] [PubMed] [Google Scholar]
  • 10.Perez-Jimenez R, Li J, Kosuri P, Sanchez-Romero I, Wiita AP, Rodriguez-Larrea D, Chueca A, Holmgren A, Miranda-Vizuete A, Becker K, Cho SH, Beckwith J, Gelhaye E, Jacquot JP, Gaucher EA, Sanchez-Ruiz JM, Berne BJ, Fernandez JM. Nat Struct Mol Biol. 2009;16:890. doi: 10.1038/nsmb.1627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Alegre-Cebollada J, Perez-Jimenez R, Kosuri P, Fernandez JM. J Biol Chem. 2010;285:18961. doi: 10.1074/jbc.R109.011932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Holmgren A. Structure. 1995;3:239. doi: 10.1016/s0969-2126(01)00153-8. [DOI] [PubMed] [Google Scholar]
  • 13.Chivers PT, Raines RT. Biochemistry. 1997;36:15810. doi: 10.1021/bi971504l. [DOI] [PubMed] [Google Scholar]
  • 14.Wahl MC, Irmler A, Hecker B, Schirmer RH, Becker K. J Mol Biol. 2005;345:1119. doi: 10.1016/j.jmb.2004.11.004. [DOI] [PubMed] [Google Scholar]
  • 15.Eklund H, Gleason FK, Holmgren A. Proteins. 1991;11:13. doi: 10.1002/prot.340110103. [DOI] [PubMed] [Google Scholar]
  • 16.Martin JL. Structure. 1995;3:245. doi: 10.1016/s0969-2126(01)00154-x. [DOI] [PubMed] [Google Scholar]
  • 17.Depuydt M, Leonard SE, Vertommen D, Denoncin K, Morsomme P, Wahni K, Messens J, Carroll KS, Collet JF. Science. 2009;326:1109. doi: 10.1126/science.1179557. [DOI] [PubMed] [Google Scholar]
  • 18.Marchler-Bauer A, Anderson JB, Cherukuri PF, DeWeese-Scott C, Geer LY, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Liebert CA, Liu C, Lu F, Marchler GH, Mullokandov M, Shoemaker BA, Simonyan V, Song JS, Thiessen PA, Yamashita RA, Yin JJ, Bryant SH. Nucleic Acids Res. 2005;33:D192. doi: 10.1093/nar/gki069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ren G, Stephan D, Xu Z, Zheng Y, Tang D, Harrison RS, Kurz M, Jarrott R, Shouldice SR, Hiniker A, Martin JL, Heras B, Bardwell JC. J Biol Chem. 2009;284:10150. doi: 10.1074/jbc.M809509200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Dyson HJ, Jeng MF, Tennant LL, Slaby I, Lindell M, Cui DS, Kuprin S, Holmgren A. Biochemistry. 1997;36:2622. doi: 10.1021/bi961801a. [DOI] [PubMed] [Google Scholar]
  • 21.Kelley RF, Richards FM. Biochemistry. 1987;26:6765. doi: 10.1021/bi00395a028. [DOI] [PubMed] [Google Scholar]
  • 22.Carvalho AT, Fernandes PA, Swart M, Van Stralen JN, Bickelhaupt FM, Ramos MJ. J Comput Chem. 2009;30:710. doi: 10.1002/jcc.21086. [DOI] [PubMed] [Google Scholar]
  • 23.Bach RD, Dmitrenko O, Thorpe C. J Org Chem. 2008;73:12. doi: 10.1021/jo702051f. [DOI] [PubMed] [Google Scholar]
  • 24.Roos G, Foloppe N, Van Laer K, Wyns L, Nilsson L, Geerlings P, Messens J. PloS Comput Biol. 2009;5:e1000461. doi: 10.1371/journal.pcbi.1000461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Roos G, Garcia-Pino A, Van Belle K, Brosens E, Wahni K, Vandenbussche G, Wyns L, Loris R, Messens J. J Mol Biol. 2007;368:800. doi: 10.1016/j.jmb.2007.02.045. [DOI] [PubMed] [Google Scholar]
  • 26.Garcia-Pino A, Martinez-Rodriguez S, Wahni K, Wyns L, Loris R, Messens J. J Mol Biol. 2009;385:1590. doi: 10.1016/j.jmb.2008.11.040. [DOI] [PubMed] [Google Scholar]
  • 27.Roos G, Geerlings P, Messens J. Protein Sci. 2010;19:190. doi: 10.1002/pro.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Heras B, Kurz M, Jarrott R, Shouldice SR, Frei P, Robin G, Cemazar M, Thöny-Meyer L, Glockshuber R, Martin JL. J Biol Chem. 2008;283:4261. doi: 10.1074/jbc.M707838200. [DOI] [PubMed] [Google Scholar]
  • 29.Dumoulin A, Grauschopf U, Bischoff M, Thöny-Meyer L, Berger-Bächi B. Arch Microbiol. 2005;184:117. doi: 10.1007/s00203-005-0024-1. [DOI] [PubMed] [Google Scholar]
  • 30.Grauschopf U, Winther JR, Korber P, Zander T, Dallinger P, Bardwell JCA. Cell. 1995;83:947. doi: 10.1016/0092-8674(95)90210-4. [DOI] [PubMed] [Google Scholar]
  • 31.Mossner E, Huber-Wunderlich M, Glockshuber R. Protein Sci. 1998;7:1233. doi: 10.1002/pro.5560070519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mossner E, Iwai H, Glockshuber R. FEBS Lett. 2000;477:21. doi: 10.1016/s0014-5793(00)01738-5. [DOI] [PubMed] [Google Scholar]
  • 33.Chivers PT, Prehoda KE, Raines RT. Biochemistry. 1997;36:4061. doi: 10.1021/bi9628580. [DOI] [PubMed] [Google Scholar]
  • 34.Lee DY, Ahn BY, Kim KS. Biochemistry. 2000;39:6652. doi: 10.1021/bi000035b. [DOI] [PubMed] [Google Scholar]
  • 35.Bulaj G, Kortemme T, Goldenberg DP. Biochemistry. 1998;37:8965. doi: 10.1021/bi973101r. [DOI] [PubMed] [Google Scholar]
  • 36.Hansen RE, Ostergaard H, Winther JR. Biochemistry. 2005;44:5899. doi: 10.1021/bi0500372. [DOI] [PubMed] [Google Scholar]
  • 37.Carvalho ATP, Fernandes PA, Ramos MJ. J Phys Chem B. 2006;110:5758. doi: 10.1021/jp053275f. [DOI] [PubMed] [Google Scholar]
  • 38.Holmgren A. J Biol Chem. 1972;247:1992. [PubMed] [Google Scholar]
  • 39.Chivers PT, Laboissiere MCA, Raines RT. EMBO J. 1996;15:2659. [PMC free article] [PubMed] [Google Scholar]
  • 40.Nelson JW, Creighton TE. Biochemistry. 1994;33:5974. doi: 10.1021/bi00185a039. [DOI] [PubMed] [Google Scholar]
  • 41.Vohnik S, Hanson C, Tuma R, Fuchs JA, Woodward C, Thomas GJ. Protein Sci. 1998;7:193. doi: 10.1002/pro.5560070120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Li HM, Hanson C, Fuchs JA, Woodward C, Thomas GJ. Biochemistry. 1993;32:5800. doi: 10.1021/bi00073a012. [DOI] [PubMed] [Google Scholar]
  • 43.Forman-Kay JD, Clore GM, Gronenborn AM. Biochemistry. 1992;31:3442. doi: 10.1021/bi00128a019. [DOI] [PubMed] [Google Scholar]
  • 44.Krimm I, Lemaire S, Ruelland E, Miginiac-Maslow M, Jaquot JP, Hirasawa M, Knaff DB, Lancelin JM. Eur J Biochem. 1998;255:185. doi: 10.1046/j.1432-1327.1998.2550185.x. [DOI] [PubMed] [Google Scholar]
  • 45.Takahashi N, Creighton TE. Biochemistry. 1996;35:8342. doi: 10.1021/bi960465v. [DOI] [PubMed] [Google Scholar]
  • 46.Kallis GB, Holmgren A. J Biol Chem. 1980;255:10261. [PubMed] [Google Scholar]
  • 47.Dyson HJ, Tennant LL, Holmgren A. Biochemistry. 1991;30:4262. doi: 10.1021/bi00231a023. [DOI] [PubMed] [Google Scholar]
  • 48.Reutimann H, Straub B, Luisi PL, Holmgren A. J Biol Chem. 1981;256:6796. [PubMed] [Google Scholar]
  • 49.Jeng MF, Campbell AP, Begley T, Holmgren A, Case DA, Wright PE, Dyson HJ. Structure. 1994;2:853. doi: 10.1016/s0969-2126(94)00086-7. [DOI] [PubMed] [Google Scholar]
  • 50.Katti SK, LeMaster DM, Eklund H. J Mol Biol. 1990;212:167. doi: 10.1016/0022-2836(90)90313-B. [DOI] [PubMed] [Google Scholar]
  • 51.Dyson HJ, Gippert GP, Case DA, Holmgren A, Wright PE. Biochemistry. 1990;29:4129. doi: 10.1021/bi00469a016. [DOI] [PubMed] [Google Scholar]
  • 52.Jeng MF, Dyson HJ. Biochemistry. 1996;35:1. doi: 10.1021/bi952404n. [DOI] [PubMed] [Google Scholar]
  • 53.Szajewski RP, Whitesides GM. J Am Chem Soc. 1980;102:2011. [Google Scholar]
  • 54.Shaked Z, Szajewski RP, Whitesides GM. Biochemistry. 1980;19:4156. doi: 10.1021/bi00559a004. [DOI] [PubMed] [Google Scholar]
  • 55.Hol WG. Prog Biophys Mol Biol. 1985;45:149. doi: 10.1016/0079-6107(85)90001-x. [DOI] [PubMed] [Google Scholar]
  • 56.Kortemme T, Creighton TE. J Mol Biol. 1995;253:799. doi: 10.1006/jmbi.1995.0592. [DOI] [PubMed] [Google Scholar]
  • 57.Forman-Kay JD, Clore GM, Wingfield PT, Gronenborn AM. Biochemistry. 1991;30:2685. doi: 10.1021/bi00224a017. [DOI] [PubMed] [Google Scholar]
  • 58.Wilson NA, Barbar E, Fuchs JA, Woodward C. Biochemistry. 1995;34:8931. doi: 10.1021/bi00028a001. [DOI] [PubMed] [Google Scholar]
  • 59.Graminski GF, Kubo Y, Armstrong RN. Biochemistry. 1989;28:3562. doi: 10.1021/bi00434a062. [DOI] [PubMed] [Google Scholar]
  • 60.Moutevelis E, Warwicker J. Protein Sci. 2004;13:2744. doi: 10.1110/ps.04804504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Biterova EI, Turanov AA, Gladyshev VN, Barycki JJ. Proc Natl Acad Sci USA. 2005;102:15018. doi: 10.1073/pnas.0504218102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Sandalova T, Zhong L, Lindqvist Y, Holmgren A, Schneider G. Proc Natl Acad Sci USA. 2001;98:9533. doi: 10.1073/pnas.171178698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Lennon BW, Williams CH, Ludwig ML. Science. 2000;289:1190. doi: 10.1126/science.289.5482.1190. [DOI] [PubMed] [Google Scholar]
  • 64.Wynn R, Cocco MJ, Richards FM. Biochemistry. 1995;34:11807. doi: 10.1021/bi00037a019. [DOI] [PubMed] [Google Scholar]
  • 65.Foloppe N, Nilsson L. Structure. 2004;12:289. doi: 10.1016/j.str.2004.01.009. [DOI] [PubMed] [Google Scholar]
  • 66.Cheng ZY, Arscott LD, Ballou DP, Williams CH., Jr Biochemistry. 2007;46:7875. doi: 10.1021/bi700442r. [DOI] [PubMed] [Google Scholar]
  • 67.Aslund F, Berndt KD, Holmgren A. J Biol Chem. 1997;272:30780. doi: 10.1074/jbc.272.49.30780. [DOI] [PubMed] [Google Scholar]
  • 68.Watson WH, Pohl J, Montfort WR, Stuchlik O, Powis G, Jones DP. J Biol Chem. 2003;278:33408. doi: 10.1074/jbc.M211107200. [DOI] [PubMed] [Google Scholar]
  • 69.Lin TY, Chen TS. Biochemistry. 2004;43:945. doi: 10.1021/bi0355138. [DOI] [PubMed] [Google Scholar]
  • 70.Schmidt H, Krauth-Siegel RL. J Biol Chem. 2003;278:46329. doi: 10.1074/jbc.M305338200. [DOI] [PubMed] [Google Scholar]
  • 71.Lundström J, Holmgren A. Biochemistry. 1993;32:6649. doi: 10.1021/bi00077a018. [DOI] [PubMed] [Google Scholar]
  • 72.Darby NJ, Creighton TE. Biochemistry. 1995;34:16770. doi: 10.1021/bi00051a027. [DOI] [PubMed] [Google Scholar]
  • 73.Quan S, Schneider I, Pan J, Von Hacht A, Bardwell JCA. J Biol Chem. 2007;282:28823. doi: 10.1074/jbc.M705291200. [DOI] [PubMed] [Google Scholar]
  • 74.Krause G, Lundstriim J, Barea JL, Pueyo de la Cuesta C, Holmgren A. J Biol Chem. 1991;266:9494. [PubMed] [Google Scholar]
  • 75.Korternme T, Darhy NJ, Creighton TE. Biochemisty. 1996;35:14503. doi: 10.1021/bi9617724. [DOI] [PubMed] [Google Scholar]
  • 76.Rossmann R, Stern D, Loferer H, Jacohi A, Glockshuher R, Hcnnccke H. FEBS Lett. 1997;406:249. doi: 10.1016/s0014-5793(97)00270-6. [DOI] [PubMed] [Google Scholar]
  • 77.Huber-Wunderlich M, Glockshuher R. Fold Des. 1998;3:161. doi: 10.1016/S1359-0278(98)00024-8. [DOI] [PubMed] [Google Scholar]
  • 78.Mossner E, Huber-Wunderlich M, Rietsch A, Beckwith J, Glockshuber R, Åslund F. J Biol Chem. 1999;274:25254. doi: 10.1074/jbc.274.36.25254. [DOI] [PubMed] [Google Scholar]
  • 79.Kanzok SM, Fechner A, Bauer H, Ulschmid JK, Muller HM, Botella-Munoz J, Schneuwly S, Schirmer R, Becker K. Science. 2001;291:643. doi: 10.1126/science.291.5504.643. [DOI] [PubMed] [Google Scholar]
  • 80.Kanzok SM, Schirmer RH, Turbachova I, Iozef R, Becker K. J Biol Chem. 2000;275:40180. doi: 10.1074/jbc.M007633200. [DOI] [PubMed] [Google Scholar]
  • 81.Reckenfelderbäumer N, Lüdemann H, Schmidt H, Steverding D, Krauth-Siegel RL. J Biol Chem. 2000;275:7547. doi: 10.1074/jbc.275.11.7547. [DOI] [PubMed] [Google Scholar]
  • 82.Gleason FK. Protein Sci. 1992;1:609. doi: 10.1002/pro.5560010507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Weissman JS, Kim PS. Science. 1991;253:1386. doi: 10.1126/science.1716783. [DOI] [PubMed] [Google Scholar]
  • 84.Wunderlich M, Jaenicke R, Glockshuber R. J Mol Biol. 1993;233:559. doi: 10.1006/jmbi.1993.1535. [DOI] [PubMed] [Google Scholar]
  • 85.Zapun A, Bardwell JCA, Creighton TE. Biochemistry. 1993;32:5083. doi: 10.1021/bi00070a016. [DOI] [PubMed] [Google Scholar]
  • 86.Moore EC, Reichard P, Thelander L. J Biol Chem. 1964;239:3445. [PubMed] [Google Scholar]
  • 87.Lin TY. Biochemistry. 1999;38:15508. doi: 10.1021/bi9907678. [DOI] [PubMed] [Google Scholar]
  • 88.Cheng ZY, Arscott LD, Ballou DP, Williams CH., Jr . In: Flavin and Flavoproteins. Nishino T, Miura R, Tanokura M, Fukui K, editors. ARchiTech Inc.; Tokyo: 2005. p. 319. [Google Scholar]
  • 89.Lennon BW, Williams CH., Jr Biochemistry. 1996;35:4704. doi: 10.1021/bi952521i. [DOI] [PubMed] [Google Scholar]
  • 90.Johnson DL, Martin LL. J Am Chem Soc. 2005;127:2018. doi: 10.1021/ja045084g. [DOI] [PubMed] [Google Scholar]
  • 91.Johnson DL, Polyak SW, Wallace JC, Martin LL. Lett Pept Sci. 2003;10:495. [Google Scholar]
  • 92.Salamon Z, Gleason FK, Tollin G. Arch Biochem Biophys. 1992;299:193. doi: 10.1016/0003-9861(92)90262-u. [DOI] [PubMed] [Google Scholar]
  • 93.Salamon Z, Tollin G, Hirasawa M, Gardetsalvi L, Strittetter AL, Knaff DB, Schurmann P. Biochim Biophys Acta. 1995;1230:114. doi: 10.1016/0005-2728(95)00042-h. [DOI] [PubMed] [Google Scholar]
  • 94.Chobot SE, Hernandez HH, Drennan CL, Elliott SJ. Angew Chem Int Ed Engl. 2007;46:4145. doi: 10.1002/anie.200604620. [DOI] [PubMed] [Google Scholar]
  • 95.Hamill MJ, Chobot SE, Hernandez HH, Drennan CL, Elliott SJ. Biochemistry. 2008;47:9738. doi: 10.1021/bi800676g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Hernandez HH, Jaquez OA, Hamill MJ, Elliott SJ, Drennan CL. Biochemistry. 2008;47:9728. doi: 10.1021/bi8006753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Chivers PT, Prehoda KE, Volkman BF, Kim BM, Markley JL, Raines RT. Biochemistry. 1997;36:14985. doi: 10.1021/bi970071j. [DOI] [PubMed] [Google Scholar]
  • 98.LeMaster DM, Springer PA, Unkefer CJ. J Biol Chem. 1997;272:29998. doi: 10.1074/jbc.272.48.29998. [DOI] [PubMed] [Google Scholar]
  • 99.LeMaster DM. Biochemistry. 1996;35:14876. doi: 10.1021/bi961607o. [DOI] [PubMed] [Google Scholar]
  • 100.Langsetmo K, Fuchs JA, Woodward C. Biochemistry. 1991;30:7603. doi: 10.1021/bi00244a032. [DOI] [PubMed] [Google Scholar]
  • 101.Jeng MF, Holmgren A, Dyson HJ. Biochemistry. 1995;34:10101. doi: 10.1021/bi00032a001. [DOI] [PubMed] [Google Scholar]
  • 102.Carvalho AT, Swart M, van Stralen JN, Fernandes PA, Ramos MJ, Bickelhaupt FM. J Phys Chem B. 2008;112:2511. doi: 10.1021/jp7104665. [DOI] [PubMed] [Google Scholar]
  • 103.Menchise V, Corbier C, Didierjean C, Saviano M, Benedetti E, Jacquot JP, Aubry A. Biochem J. 2001;359:65. doi: 10.1042/0264-6021:3590065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Krause G, Holmgren A. J Biol Chem. 1991;266:4056. [PubMed] [Google Scholar]
  • 105.Langsetmo K, Fuchs J, Woodward C. Biochemistry. 1989;28:3211. doi: 10.1021/bi00434a015. [DOI] [PubMed] [Google Scholar]
  • 106.Kadokura H, Tian H, Zander T, Bardwell JC, Beckwith J. Science. 2004;303:534. doi: 10.1126/science.1091724. [DOI] [PubMed] [Google Scholar]
  • 107.Eklund H, Cambillau C, Sjoberg BM, Holmgren A, Jornvall H, Hoog JO, Branden CI. EMBO J. 1984;3:1443. doi: 10.1002/j.1460-2075.1984.tb01994.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Kumar JK, Tabor S, Richardson CC. Proc Natl Acad Sci USA. 2004;101:3759. doi: 10.1073/pnas.0308701101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Creighton TE. J Mol Biol. 1975;96:767. doi: 10.1016/0022-2836(75)90151-5. [DOI] [PubMed] [Google Scholar]
  • 110.Holmgren A. J Biol Chem. 1979;254:9113. [PubMed] [Google Scholar]
  • 111.Holmgren A. J Biol Chem. 1979;254:9627. [PubMed] [Google Scholar]
  • 112.Haberlein I, Wurfel M, Follmann H. Biochim Biophys Acta. 1992;1121:293. doi: 10.1016/0167-4838(92)90159-b. [DOI] [PubMed] [Google Scholar]
  • 113.Haberlein I, Vogeler B. Biochim Biophys Acta. 1995;1253:169. doi: 10.1016/0167-4838(95)00153-1. [DOI] [PubMed] [Google Scholar]
  • 114.Braun H, Lichter A, Haberlein I. Eur J Biochem. 1996;240:781. doi: 10.1111/j.1432-1033.1996.0781h.x. [DOI] [PubMed] [Google Scholar]
  • 115.Knaff DB. Physiol Planta. 2000;110:309. [Google Scholar]
  • 116.Buchanan BB, Schürmann P, Decottignies P, Lozano RM. Arch Biochem Biophys. 1994;314:257. doi: 10.1006/abbi.1994.1439. [DOI] [PubMed] [Google Scholar]
  • 117.Buchanan BB. Arch Biochem Biophys. 1991;288:1. doi: 10.1016/0003-9861(91)90157-e. [DOI] [PubMed] [Google Scholar]
  • 118.Geck MK, Larimer FW, Hartman FC. J Biol Chem. 1996;271:24736. doi: 10.1074/jbc.271.40.24736. [DOI] [PubMed] [Google Scholar]
  • 119.Villeret V, Huang S, Zhang Y, Xue Y, Lipscomb WN. Biochemistry. 1995;34:4299. doi: 10.1021/bi00013a019. [DOI] [PubMed] [Google Scholar]
  • 120.Rodríguez-Suárez RJ, Mora-García S, Wolosiuk RA. Biochem Biophys Res Commun. 1997;232:388. doi: 10.1006/bbrc.1997.6242. [DOI] [PubMed] [Google Scholar]
  • 121.Jacquot JP, López-Jaramillo J, Miginiac-Maslow M, Lemaire S, Cherfils J, Chueca A, López-Gorge J. FEBS Lett. 1997;401:143. doi: 10.1016/s0014-5793(96)01459-7. [DOI] [PubMed] [Google Scholar]
  • 122.Mora-Garcia S, Rodriguez-Suarez R, Wolosiuk RA. J Biol Chem. 1998;273:16273. doi: 10.1074/jbc.273.26.16273. [DOI] [PubMed] [Google Scholar]
  • 123.Schwarz O, Schürmann P, Strotmann H. J Biol Chem. 1997;272:16924. doi: 10.1074/jbc.272.27.16924. [DOI] [PubMed] [Google Scholar]
  • 124.López-Jaramillo J, Chueca A, Jacquot JP, Hermoso R, Lázaro JJ, Sahrawy M, López-Gorge J. Plant Physiol. 1997;114:1169. doi: 10.1104/pp.114.4.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.de Lamotte-Guery F, Miginiac-Maslow M, Decottignies P, Stein M, Minard P, Jacquot JP. Eur J Biochem. 1991;196:287. doi: 10.1111/j.1432-1033.1991.tb15816.x. [DOI] [PubMed] [Google Scholar]
  • 126.Ericson M, Jodin J, Lenman N, Glimelius K, Joseffson L, Rask L. J Biol Chem. 1986;261:14576. [PubMed] [Google Scholar]
  • 127.Schreiber G, Fersht AR. Nat Struct Biol. 1996;3:427. doi: 10.1038/nsb0596-427. [DOI] [PubMed] [Google Scholar]
  • 128.Balmer Y, Koller A, del Val G, Schürmann P, Buchanan BB. Photosynth Res. 2004;79:275. doi: 10.1023/B:PRES.0000017207.88257.d4. [DOI] [PubMed] [Google Scholar]
  • 129.Krnajski Z, Gilberger TW, Walter RD, Muller S. Mol Biochem Parasitol. 2001;112:219. doi: 10.1016/s0166-6851(00)00372-8. [DOI] [PubMed] [Google Scholar]
  • 130.Collet JF, Messens J. Antioxid Redox Signal. 2010;13:1205. doi: 10.1089/ars.2010.3114. [DOI] [PubMed] [Google Scholar]
  • 131.Wiita AP, Perez-Jimenez R, Walther KA, Gräter F, Berne BJ, Holmgren A, Sanchez-Ruiz JM, Fernandez JM. Nature. 2007;450:124. doi: 10.1038/nature06231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Weichsel A, Gasdaska JR, Powis G, Montfort WR. Structure. 1996;4:735. doi: 10.1016/s0969-2126(96)00079-2. [DOI] [PubMed] [Google Scholar]
  • 133.Capitani G, Markovic-Housley Z, DelVal G, Morris M, Jansonius JN, Schurmann P. J Mol Biol. 2000;302:135. doi: 10.1006/jmbi.2000.4006. [DOI] [PubMed] [Google Scholar]
  • 134.Williams CH, Arscott LD, Müller S, Lennon BW, Ludwig M, Wang PF, Veine DM, Becker K, Schirmer RH. Eur J Biochem. 2000;267:6110. doi: 10.1046/j.1432-1327.2000.01702.x. [DOI] [PubMed] [Google Scholar]
  • 135.Watson WH, Yang X, Choi YE, Jones DP, Kehrer JP. Toxicol Sci. 2004;78:3. doi: 10.1093/toxsci/kfh050. [DOI] [PubMed] [Google Scholar]
  • 136.Weichsel A, Kem M, Montfort WR. Protein Sci. 2010;19:1801. doi: 10.1002/pro.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Hall G, Emsley J. Protein Sci. 2010;19:1807. doi: 10.1002/pro.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.Carvalho AP, Fernandes PA, Ramos MJ. Prog Biophys Mol Biol. 2006;91:229. doi: 10.1016/j.pbiomolbio.2005.06.012. [DOI] [PubMed] [Google Scholar]
  • 139.Debarbieux L, Beckwith J. Proc Natl Acad Sci USA. 1998;95:10751. doi: 10.1073/pnas.95.18.10751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Masip L, Klein-Marcuschamer D, Quan S, Bardwell JC, Georgiou G. J Biol Chem. 2008;283:840. doi: 10.1074/jbc.M705147200. [DOI] [PubMed] [Google Scholar]
  • 141.Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. Nucleic Acids Res. 2000;28:235. doi: 10.1093/nar/28.1.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Sayle R, Milner-White E. J Trends Biochem Sci. 1995;20:374. doi: 10.1016/s0968-0004(00)89080-5. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

Supplementary Figure 1. Relationships between Em and Trx reactivity with small molecule disulfide reagents. WtTrx (gray circle) and the three Trx variants, PDI-like Trx (black circle), DsbA-like Trx (gray diamond), and Grx-like Trx (black diamond) showed a reasonably linear relationship between their Em values and their reactivity in reducing DTTox (A), lipoic acid (B), sulfate (C), methionine sulfoxide (D), and in oxidizing DTTred (E). (F) Trx(s) from different species showed poor correlation between the Em values with their reactivity with GSSG. The preliminary data is from Table 3.

Supplementary Figure 2. Differential role of the redox potential and binding affinity in regulating Trx activity to react with proteins. (A) The correlation between the Em of Trx and DsbA-, PDI- and Grx-like variants, and their activity (kcat/Km) in reacting with NADPH catalyzed by TrxR. (B) The relationship between activity of Trx and DsbA-, PDI- and Grx-like variants and their substrate affinity (1/Km) toward TrxR. (C and D) The relationships of Em of Trx and D26A, P34S, and P76A variants with their activities in reacting with NADPH catalyzed by TrxR or ribonucleotide diphosphate reductase (RDR), respectively. (E and F) The relationships between the activities of variants D26A, P34S, and P76A and their substrate affinity (1/Km) toward TrxR or RDR, respectively. The preliminary data is from Table 2. Note that both Fig. 4B and 4E show only 3 points because two of the four points in each panels overlapped. In Fig 4B, two points are located at (0.83, 1.9), and (0.56, 14) in Fig 4E.

RESOURCES